Stay updated with breaking news from Hitgen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
April 8, 2024Press Releases Vernalis announces a drug discovery collaboration with C4X Discovery in inflammatory disease Vernalis ...
/PRNewswire/ -- Hox Therapeutics Ltd ("Hox") a private biotechnology company developing highly targeted cancer therapies and Vernalis (R&D) Ltd ("Vernalis"), a...
/PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a partnership with The...
/PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term...
/PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research service...